Metastatic Breast Cancer, Triple Negative Breast Cancer Completed Phase 3 Trials for Vinorelbine (DB00361)

Also known as: Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Triple-negative Metastatic Breast Cancer / Triple Negative Metastatic Breast Cancer

IndicationStatusPhase
DBCOND0074793 (Metastatic Breast Cancer, Triple Negative Breast Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02555657Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)Treatment